Gw Pharma ADR (GWPH) Stock News
NASDAQ:GWPH - Nasdaq -
GWPH Latest News, Press Relases and Analysis
IDEAYA Biosciences Appoints Douglas B. Snyder as Senior Vice President, General Counsel
/PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted...
Jazz Pharmaceuticals Files Patent Infringement Against Generic Drugmakers In New Jersey's District Court
Jazz Pharmaceuticals (NASDAQ: JAZZ), a drug company behind the CBD-based medication Epidiolex, recently filed a lawsuit against Teva Pharmaceutical Industries Ltd (NYS
Marijuana As An Appetite Suppressant? It's A Possibility
Using cannabis as an appetite suppressant for weight management may seem counterintuitive, but one rare cannabinoid may have just that effect. Delta-9 (d-9)-dominant tetrahydrocannabivarin (THCV) has been found to curb hunger and also has the potential to help maintain normal blood sugar levels.
Snoop Dogg-Backed Oxford Cannabinoid Fluctuates in Debut
Oxford Cannabinoid Technologies, the U.K. prescription drug company that counts rapper Snoop Dogg among its investors, swung wildly between gains and losses on its London stock-market debut, capping a volatile week for investors.
Snoop Dogg-Backed Oxford Cannabinoid Fluctuates in Stock Debut
Oxford Cannabinoid Technologies, which counts tobacco giant Imperial Brands Plc and rapper Snoop Dogg among its investors, swung between big gains and losses as it debuted on the London Stock Exchange.
Snoop Dogg-Backed Pharma Firm Oxford Cannabinoid to List in U.K.
Oxford Cannabinoid Technologies, which counts tobacco giant Imperial Brands Plc and rapper Snoop Dogg among its investors, is set to start trading Friday on the London Stock Exchange.
Medical Stocks Jazz, Horizon Are Accelerating But Iqvia Is Hitting The Brakes
Jazz Pharmaceuticals and Horizon Therapeutics are among a cadre of accelerating medical stocks, while big names like Iqvia Holdings are hitting the brakes.
Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc
Mentions: JAZZ
Jazz Pharma Easily Beats Earnings Views, But Sales Come In Light
Late Tuesday, Jazz Pharma reported adjusted earnings of $3.92 per share on $607.58 million in sales for its first quarter. Jazz stock was unmoved.
Mentions: JAZZ
Top Medical Marijuana Stocks In 2021? 2 For Your May Watchlist
Are Medical Marijuana Stock Going To Make Investors Rich In The Future?
GW Pharmaceuticals Stockholders Approve Acquisition by Jazz Pharmaceuticals
Jazz is about to get the top cannabis-derived drug on the market, in addition to a robust pipeline.
Mentions: JAZZ
Looking For Marijuana Stocks To Buy On Robinhood? 2 For Your Watchlist Next Week
Are These Top Cannabis Stocks To Invest In Right Now?